Cannaleaf Development
Mansfield, Massachusetts
Find prospects like Cannaleaf Development
Get a list of similar companies, matched by industry, size and location, ready for outreach.
Free sample of 25 companies by email within one business day. No spam: we only use your email for this request.
About Cannaleaf Development
Curaleaf is a leading medical and recreational marijuana dispensary in the United States. We serve 350k+ registered patients across 23 states. Shop now!
Cannaleaf Development is one of 1,441,867 companies listed in Massachusetts.
Business Contact Information
- Phone
- +1 (508) 7310100
- Website
- http://www.curaleaf.com
- Address
- 905 S Main St, Mansfield, Massachusetts, 02048, United States
Company Details
- Employees
- 2,500
- Annual Revenue
- $100.0M
Cannaleaf Development: frequently asked questions
What does Cannaleaf Development do?
Curaleaf is a leading medical and recreational marijuana dispensary in the United States. We serve 350k+ registered patients across 23 states. Shop now!
Where is Cannaleaf Development located?
Cannaleaf Development is located at 905 S Main St, Mansfield, Massachusetts, 02048, United States.
How many employees does Cannaleaf Development have?
Cannaleaf Development has about 2,500 employees.
What is Cannaleaf Development's annual revenue?
Cannaleaf Development's annual revenue is estimated at $100.0M.
How can I contact Cannaleaf Development?
Its website is www.curaleaf.com and its phone number is +1 (508) 7310100.
Largest companies in Massachusetts
Largest companies on Factur
Manufacturing sales in Massachusetts, 2026
In Massachusetts, Factur's 2026 study counted 32 manufacturing quotes worth $961K and 7 purchase orders over 12 months: 22% of quotes became orders, against 21% nationally. See the Massachusetts data.
Own this business?
Keep your profile accurate — or ask us to take it down. We acknowledge requests within 7 days and resolve them within 30 days.
Prefer email? privacy@facturmfg.com
Add this badge to your website — show visitors you're listed on Factur Data.